VNDA

FDA accepts Vanda's iloperidone NDA resubmission - 11/21 - 09:33 AM ET

UPDATE 1-Vanda says FDA accepts schizophrenia drug response - 11/20 - 09:35 AM ET

VNDA: FDA Accepts Resubmission of NDA for Iloperidone - 11/20 - 09:10 AM ET

BRIEF-Vanda says FDA accepts iloperidone resubmission - 11/20 - 09:09 AM ET

FDA Accepts Vanda Pharmaceuticals Iloperidone Resubmission and Sets New Action Date - 11/20 - 09:02 AM ET

BRIEF-Vanda Pharmaceuticals reports third quarter 2008 results - 10/30 - 07:25 AM ET

VANDA PHARMACEUTICALS INC SEES FY 2008 SHR LOSS ABOUT $2.10 - 10/30 - 07:09 AM ET

VANDA PHARMACEUTICALS INC Q3 SHR LOSS $0.41 - 10/30 - 07:08 AM ET

VANDA PHARMA SETS TRIGGER AT 15 PERCENT FOR RIGHTS TO BECOME EXERCISABLE - 09/25 - 09:46 AM ET

Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights - 09/25 - 09:40 AM ET

Vanda Pharmaceuticals Provides Update on Iloperidone - 09/11 - 09:11 AM ET

Form 4 Oracle: Boston, MA -- Form4Oracle: Insider Trading Report: Vanda Pharmaceuticals Inc. (VNDA) - 08/12 - 06:26 AM ET

VNDA: Q2 Earnings Call @ 10:30 ET Today [delayed] - 08/05 - 07:51 AM ET

Vanda Pharmaceuticals Reports Second Quarter 2008 Results - 08/05 - 06:30 AM ET

Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008 - 07/31 - 01:46 PM ET

Vanda receives FDA not approvable letter for schizophrenia drug - 07/30 - 07:08 AM ET

Vanda shares dive 73 percent to 90 cents - 07/29 - 12:40 PM ET

Vanda Pharmaceuticals Closes At New Low - 07/28 - 04:23 PM ET

VANDA PHARMACEUTICALS DOWN 57% AT $1.45 IN PREMARKET TRADING - 07/28 - 09:25 AM ET

Vanda Pharmaceuticals Plunges In Pre-Market After Receiving FDA Not Approvable Letter - 07/28 - 08:37 AM ET

Page 1 of 4     1  2   3   4      Previous  |  Next

<< Back to Stock Index